EDITORIALS

Myelodysplasia and Acute Leukemia After Autologous Bone Marrow Transplantation

James O. Armitage

JCO Mar 1 2000: 945. [Full Text] [PDF]

HEMATOLOGIC MALIGNANCIES
	Therapy-Related Myelodysplasia and Secondary Acute Myelogenous Leukemia After High-Dose Therapy With Autologous Hematopoietic Progenitor-Cell Support for Lymphoid Malignancies
	Ivana N. M. Micallef, Debra M. Lillington, John Apostolidis, John A. L. Amess, Michael Neat, Janet Matthews, Taane Clark, James M. Foran, Ashiq Salam, T. Andrew Lister, and Ama Z. S. Rohatiner
	JCO Mar 1 2000: 947. [Abstract] [Full Text] [PDF]
	Low-Dose 5-Aza-2'-Deoxycytidine, a DNA Hypomethylating Agent, for the Treatment of High-Risk Myelodysplastic Syndrome: A Multicenter Phase II Study in Elderly Patients
	P. Wijermans, M. Lübbert, G. Verhoef, A. Bosly, C. Ravoet, M. Andre, and A. Ferrant
	JCO Mar 1 2000: 956. [Abstract] [Full Text] [PDF]
	Allogeneic Bone Marrow Transplantation for Therapy-Related Myelodysplastic Syndrome and Acute Myeloid Leukemia: A Long-Term Study of 70 Patients—Report of the French Society of Bone Marrow Transplantation
	I. Yakoub-Agha, P. de La Salmonière, P. Ribaud, L. Sutton, E. Wattel, M. Kuentz, J. P. Jouet, G. Marit, N. Milpied, E. Deconinck, N. Gratecos, M. Leporrier, I. Chabbert, D. Caillot, G. Damaj, C. Dauriac, F. Dreyfus, S. François, L. Molina, M. L. Tanguy, S. Chevret, and E. Gluckman
	JCO Mar 1 2000: 963. [Abstract] [Full Text] [PDF]
	Assessment of the Stanford V Regimen and Consolidative Radiotherapy for Bulky and Advanced Hodgkin’s Disease: Eastern Cooperative Oncology Group Pilot Study E1492
	Sandra J. Horning, Jovanne Williams, Nancy L. Bartlett, John M. Bennett, Richard T. Hoppe, Donna Neuberg, and Peter Cassileth
	JCO Mar 1 2000: 972. [Abstract] [Full Text] [PDF]
	Prospective Randomized Comparison of Single-Dose Versus Hyperfractionated Total-Body Irradiation in Patients With Hematologic Malignancies
	Theodore Girinsky, Ellen Benhamou, Jean-Henry Bourhis, Frederic Dhermain, Dolores Guillot-Valls, Valerie Ganansia, Monique Luboinski, Adriana Perez, Jean Marc Cosset, Gérard Socie, Daniel Baume, Nourédine Bouaouina, Edith Briot, Anne Beaudre, André Bridier, and Jose Luis Pico
	JCO Mar 1 2000: 981. [Abstract] [Full Text] [PDF]
	Phase I Study of Fludarabine Plus Cyclophosphamide in Patients With Previously Untreated Low-Grade Lymphoma: Results and and Long-Term Follow-Up—A Report From the Eastern Cooperative Oncology Group
	Howard S. Hochster, Martin M. Oken, Jane N. Winter, Leo I. Gordon, Bruce G. Raphael, John M. Bennett, and Peter A. Cassileth
	JCO Mar 1 2000: 987. [Abstract] [Full Text] [PDF]
	Pharmacokinetics of Nelarabine and 9-Beta-D-Arabinofuranosyl Guanine in Pediatric and Adult Patients During a Phase I Study of Nelarabine for the Treatment of Refractory Hematologic Malignancies
	David F. Kisor, William Plunkett, Joanne Kurtzberg, Beverly Mitchell, Jeffrey P. Hodge, Timothy Ernst, Michael J. Keating, and Varsha Gandhi
	JCO Mar 1 2000: 995. [Abstract] [Full Text] [PDF]

PEDIATRIC ONCOLOGY
	Cognitive and Academic Functioning in Survivors of Pediatric Bone Marrow Transplantation
	Sean Phipps, Maggi Dunavant, Deo K. Srivastava, Laura Bowman, and Raymond K. Mulhern
	JCO Mar 1 2000: 1004. [Abstract] [Full Text] [PDF]
	"Low-Risk" Prediction Rule for Pediatric Oncology Patients Presenting With Fever and Neutropenia
	Robert J. Klaassen, T. Robin Goodman, Ba Pham, and John J. Doyle
	JCO Mar 1 2000: 1012. [Abstract] [Full Text] [PDF]
	Proton Magnetic Resonance Spectroscopic Imaging in Children With Recurrent Primary Brain Tumors
	Katherine E. Warren, Joseph A. Frank, Jeanette L. Black, Rene S. Hill, Josef H. Duyn, Alberta A. Aikin, Bobbi K. Lewis, Peter C. Adamson, and Frank M. Balis
	JCO Mar 1 2000: 1020. [Abstract] [Full Text] [PDF]

BRAIN TUMORS
	TrkC Expression Predicts Good Clinical Outcome in Primitive Neuroectodermal Brain Tumors
	M. A. Grotzer, A. J. Janss, K.-M. Fung, J. A. Biegel, L. N. Sutton, L. B. Rorke, H. Zhao, A. Cnaan, P. C. Phillips, V. M.-Y. Lee, and J. Q. Trojanowski
	JCO Mar 1 2000: 1027. [Abstract] [Full Text] [PDF]

GENITOURINARY CANCER
	Serum Human Glandular Kallikrein-2 Protease Levels Predict the Presence of Prostate Cancer Among Men With Elevated Prostate-Specific Antigen
	Robert K. Nam, Eleftherios P. Diamandis, Ants Toi, John Trachtenberg, Angeliki Magklara, Andreas Scorilas, Panayotis A. Papnastasiou, Michael A. S. Jewett, and Steven A. Narod
	JCO Mar 1 2000: 1036. [Abstract] [Full Text] [PDF]
	Androgen Deprivation and Four Courses of Fixed-Schedule Suramin Treatment in Patients With Newly Diagnosed Metastatic Prostate Cancer: A Southwest Oncology Group Study
	Maha Hussain, Emily I. Fisher, Daniel P. Petrylak, John O’Connor, David P. Wood, Eric J. Small, Mario A. Eisenberger, and E. David Crawford
	JCO Mar 1 2000: 1043. [Abstract] [Full Text] [PDF]
	Neoadjuvant Chemotherapy and Hormonal Therapy Followed by Radical Prostatectomy: Feasibility and Preliminary Results
	Curtis A. Pettaway, Louis L. Pisters, Patricia Troncoso, Joel Slaton, Laury Finn, Kazumi Kamoi, and Christopher J. Logothetis
	JCO Mar 1 2000: 1050. [Abstract] [Full Text] [PDF]
	Phase II Study of Cisplatin and Paclitaxel in Advanced Carcinoma of the Urothelium: An Eastern Cooperative Oncology Group Study
	Robert Dreicer, Judith Manola, Bruce J. Roth, Michael B. Cohen, Alan K. Hatfield, and George Wilding
	JCO Mar 1 2000: 1058. [Abstract] [Full Text] [PDF]

GYNECOLOGIC CANCER
	Topotecan Has Substantial Antitumor Activity as First-Line Salvage Therapy in Platinum-Sensitive Epithelial Ovarian Carcinoma: A Gynecologic Oncology Group Study
	William P. McGuire, John A. Blessing, Michael A. Bookman, Samuel S. Lentz, and Charles J. Dunton
	JCO Mar 1 2000: 1062. [Abstract] [Full Text] [PDF]

BREAST CANCER
	Evaluation of Soy Phytoestrogens for the Treatment of Hot Flashes in Breast Cancer Survivors: A North Central Cancer Treatment Group Trial
	Susan K. Quella, Charles L. Loprinzi, Debra L. Barton, James A. Knost, Jeff A. Sloan, Beth I. LaVasseur, Debra Swan, Kenneth R. Krupp, Kathy D. Miller, and Paul J. Novotny
	JCO Mar 1 2000: 1068. [Abstract] [Full Text] [PDF]
	High Local Recurrence Risk After Breast-Conserving Therapy in Node-Negative Premenopausal Breast Cancer Patients Is Greatly Reduced by One Course of Perioperative Chemotherapy: A European Organization for Research and Treatment of Cancer Breast Cancer Cooperative Group Study
	Paula H. M. Elkhuizen, Henk-Jan van Slooten, Pieter C. Clahsen, Jo Hermans, Cornelis J. H. van de Velde, Lambert C. J. M. van den Broek, and Marc J. van de Vijver
	JCO Mar 1 2000: 1075. [Abstract] [Full Text] [PDF]
	Trauma History as a Predictor of Psychologic Symptoms in Women With Breast Cancer
	Bonnie L. Green, Janice L. Krupnick, Julia H. Rowland, Steven A. Epstein, Patricia Stockton, Ilyse Spertus, and Nicole Stern
	JCO Mar 1 2000: 1084. [Abstract] [Full Text] [PDF]

GASTROINTESTINAL CANCER
	Long-Term Prognosis After Resection of Hepatocellular Carcinoma Associated With Hepatitis B–Related Cirrhosis
	Ronnie Tung-Ping Poon, Sheung-Tat Fan, Chung-Mau Lo, Chi-Leung Liu, Irene Oi-Lin Ng, and John Wong
	JCO Mar 1 2000: 1094. [Abstract] [Full Text] [PDF]

LUNG CANCER
	Multi-Institutional Phase I/II Trial of Paclitaxel, Cisplatin, and Etoposide With Concurrent Radiation for Limited-Stage Small-Cell Lung Carcinoma
	Nathan Levitan, Afshin Dowlati, Donald Shina, Mark Craffey, Wilma Mackay, Russell DeVore, James Jett, Scot C. Remick, Alex Chang, and David Johnson
	JCO Mar 1 2000: 1102. [Abstract] [Full Text] [PDF]

CANCER RELATED COMPLICATIONS
	Prospective Analysis of Staphylococcus aureus Bacteremia in Nonneutropenic Adults With Malignancy
	Ajay K. Gopal, Vance G. Fowler, Jr, Manish Shah, Diane Gesty-Palmer, Kieren A. Marr, R. Scott McClelland, Li Kuo Kong, Geoffrey S. Gottlieb, Kevin Lanclos, Jennifer Li, Daniel J. Sexton, and G. Ralph Corey
	JCO Mar 1 2000: 1110. [Abstract] [Full Text] [PDF]

PHASE I AND CLINICAL PHARMACOLOGY
	Phase I and Pharmacokinetic Study of Irinotecan and Docetaxel in Patients With Advanced Solid Tumors: Preliminary Evidence of Clinical Activity
	Alex A. Adjei, Cheri E. Klein, Helen Kastrissios, Richard M. Goldberg, Steven R. Alberts, Henry C. Pitot, Jeff A. Sloan, Joel M. Reid, Lorelei J. Hanson, Pamela Atherton, Joseph Rubin, and Charles Erlichman
	JCO Mar 1 2000: 1116. [Abstract] [Full Text] [PDF]
	Phase I Study of Paclitaxel in Combination With a Multidrug Resistance Modulator, PSC 833 (Valspodar), in Refractory Malignancies
	Paula M. Fracasso, Peter Westerveldt, Carole A. Fears, D. Marc Rosen, Eleanor G. Zuhowski, Lorraine A. Cazenave, Manuel Litchman, and Merrill J. Egorin
	JCO Mar 1 2000: 1124. [Abstract] [Full Text] [PDF]

BIOLOGY OF NEOPLASIA
	Matrix Metalloproteinases: Biologic Activity and Clinical Implications
	Amy R. Nelson, Barbara Fingleton, Mace L. Rothenberg, and Lynn M. Matrisian
	JCO Mar 1 2000: 1135. [Abstract] [Full Text] [PDF]

DIAGNOSIS IN ONCOLOGY

Case 1: Hodgkins’s Disease Presenting as a Cystic Neck Mass

James Butera and Nancy J. Freeman

JCO Mar 1 2000: 1150. [Full Text] [PDF]

Case 2: Meningeal Relapse in Hodgkin’s Disease

C. S. Chim, T. W. Shek, G. C. Ooi, and R. Liang

JCO Mar 1 2000: 1153. [Full Text] [PDF]

ART OF ONCOLOGY

To Hydrate or Not to Hydrate: How Should It Be?

Eduardo Bruera and Neil MacDonald

JCO Mar 1 2000: 1156–1158. [Full Text] [PDF]

CORRESPONDENCE

BRCA1/2 Germline Mutations: A Marker for Radioresistance or Radiosensitivity?

Silvia C. Formenti, Susan Preston-Martin, and Bruce G. Haffty

JCO Mar 1 2000: 1159. [Full Text] [PDF]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.